OBJECTIVE: Little is known about the developmental trajectory of cortisol levels in preterm
infants after hospital discharge. STUDY DESIGN: In a cohort of 225 infants (gestational age …

OBJECTIVE: To determine the prevalence of low cortisol values and to evaluate clinical
responses to hydrocortisone in ill term and near-term newborns. STUDY DESIGN …

Objective: To assess the effect of moderately early postnatal dexamethasone treatment on
growth and neurodevelopmental outcome in preterm infants. Methods: Thirty preterm infants …

Previous studies reported impaired cerebral cortical gray matter (CGM) development and
neurodevelopmental impairment after neonatal dexamethasone treatment for chronic lung …

OBJECTIVE: Extremely low birth weight (ELBW) infants are at risk for hypotension. Abnormal
adrenal function may play a role in the pathogenesis of hypotension, and therefore, the …

BACKGROUND. The duration and severity of systemic hypotension have been related with
altered neurodevelopment. Cerebral circulation is pressure-passive in low birth weight …

Objective: To compare the neurodevelopmental outcomes at 18–22 months' corrected age
of extremely premature infants exposed to a complete course, an incomplete course or no …

OBJECTIVE. We compared the development of adverse neurodevelopmental outcomes at
corrected ages of 18 to 22 months for extremely low birth weight infants exposed prenatally …

Abstract Background The Multiple Courses of Antenatal Corticosteroids for Preterm Birth
Study (MACS) showed no benefit in the reduction of major neonatal mortality/morbidity or …

A relatively brief course of antenatal glucocorticoids (ACS), given to reduce the severity of
respiratory distress syndrome in preterm infants, improves survival and appears to protect …